BR9609393A - Composição injetável de colágeno; segmentos de fibra de colágeno reconstituìdos. - Google Patents

Composição injetável de colágeno; segmentos de fibra de colágeno reconstituìdos.

Info

Publication number
BR9609393A
BR9609393A BR9609393-5A BR9609393A BR9609393A BR 9609393 A BR9609393 A BR 9609393A BR 9609393 A BR9609393 A BR 9609393A BR 9609393 A BR9609393 A BR 9609393A
Authority
BR
Brazil
Prior art keywords
collagen
pct
fiber segments
reconstituted
injectable composition
Prior art date
Application number
BR9609393-5A
Other languages
English (en)
Inventor
Robert M Carr Jr
John F Cavallaro
Lisa M Bryant
David W Donavan
Paul D Kemp
Original Assignee
Organogenesis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organogenesis Inc filed Critical Organogenesis Inc
Publication of BR9609393A publication Critical patent/BR9609393A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005—The prosthesis being constructed from a particular material
    • A61F2310/00365—Proteins; Polypeptides; Degradation products thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Artificial Filaments (AREA)
  • Manufacture, Treatment Of Glass Fibers (AREA)
  • Prostheses (AREA)

Abstract

"COMPOSIçãO INJETáVEL DE COLáGENO; SEGMENTOS DE FIBRA DE COLáGENO RECONSTITUìDOS". A presente invenção proporciona composições de colágeno na forma de segmentos de fibra de colágeno reconstituídos, métodos para a produção de segmentos de fibra de colágeno e utilização de tais segmentos de fibra de colágeno como uma composição injetável de colágeno para aumento dos tecidos macios, reparo de tecidos e administração de medicamentos. A presente invenção proporciona também composições de colágeno possuindo características aperfeiçoadas para bio-remodelação. A presente invenção propicia também métodos para a produção de composições altamente concentradas de colágeno.
BR9609393-5A 1995-06-07 1996-06-07 Composição injetável de colágeno; segmentos de fibra de colágeno reconstituìdos. BR9609393A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48309295A 1995-06-07 1995-06-07
PCT/US1996/009861 WO1996040216A1 (en) 1995-06-07 1996-06-07 Reconstituted collagen fiber segment compositions and methods of preparation thereof

Publications (1)

Publication Number Publication Date
BR9609393A true BR9609393A (pt) 1999-12-21

Family

ID=23918627

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9609393-5A BR9609393A (pt) 1995-06-07 1996-06-07 Composição injetável de colágeno; segmentos de fibra de colágeno reconstituìdos.

Country Status (10)

Country Link
US (1) US5997896A (pt)
EP (1) EP0831882B1 (pt)
JP (1) JP3647465B2 (pt)
AT (1) ATE276757T1 (pt)
AU (1) AU722322B2 (pt)
BR (1) BR9609393A (pt)
DE (1) DE69633444T2 (pt)
ES (1) ES2229277T3 (pt)
PT (1) PT831882E (pt)
WO (1) WO1996040216A1 (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563232B2 (en) * 2000-09-12 2013-10-22 Lifenet Health Process for devitalizing soft-tissue engineered medical implants, and devitalized soft-tissue medical implants produced
US6743574B1 (en) 2000-09-12 2004-06-01 Lifenet Process for devitalizing soft-tissue engineered medical implants, and devitalized soft-tissue medical implants produced
US6734018B2 (en) * 1999-06-07 2004-05-11 Lifenet Process for decellularizing soft-tissue engineered medical implants, and decellularized soft-tissue medical implants produced
US6293970B1 (en) * 1998-06-30 2001-09-25 Lifenet Plasticized bone and soft tissue grafts and methods of making and using same
US7063726B2 (en) * 1998-06-30 2006-06-20 Lifenet Plasticized bone grafts and methods of making and using same
GB2345638A (en) * 1998-09-11 2000-07-19 Tissue Science Lab Limited Injectable collagen compositions
US6361551B1 (en) * 1998-12-11 2002-03-26 C. R. Bard, Inc. Collagen hemostatic fibers
ES2325977T3 (es) * 1999-09-28 2009-09-28 Organogenesis Inc. Fibrillas de colageno obtenidas por biotecnologia.
US6592794B1 (en) 1999-09-28 2003-07-15 Organogenesis Inc. Process of making bioengineered collagen fibrils
CA2402000A1 (en) * 2000-03-06 2001-09-13 Tei Biosciences, Inc. Injectable bio-compatible material and methods of use
US20070038244A1 (en) * 2001-06-08 2007-02-15 Morris Edward J Method and apparatus for sealing access
US7993365B2 (en) * 2001-06-08 2011-08-09 Morris Innovative, Inc. Method and apparatus for sealing access
JP2003193328A (ja) * 2001-12-19 2003-07-09 Nipro Corp コラーゲン単糸の製造方法
WO2003072128A2 (en) * 2002-02-22 2003-09-04 Ebi, L.P. Methods and compositions for treating bone or cartilage defects
US7166133B2 (en) * 2002-06-13 2007-01-23 Kensey Nash Corporation Devices and methods for treating defects in the tissue of a living being
US20050033157A1 (en) * 2003-07-25 2005-02-10 Klein Dean A. Multi-modality marking material and method
JP4401226B2 (ja) * 2004-04-16 2010-01-20 ミドリホクヨー株式会社 コラーゲン化粧料、その製造方法、可溶化コラーゲン繊維及びその製造装置
US20060246033A1 (en) * 2005-03-02 2006-11-02 Cook Biotech Incorporated Injectable bulking agent compositions
JP4356654B2 (ja) * 2005-06-02 2009-11-04 ニプロ株式会社 コラーゲン単糸の製造方法
US20090024224A1 (en) 2007-07-16 2009-01-22 Chen Silvia S Implantation of cartilage
US20090024106A1 (en) * 2007-07-17 2009-01-22 Morris Edward J Method and apparatus for maintaining access
US20090054350A1 (en) * 2007-08-23 2009-02-26 Jean-Louis Tayot Process for the sterile concentration of collagen preparations, and collagen preparations obtained
WO2009155236A1 (en) 2008-06-16 2009-12-23 Morris Innovative Research, Inc. Method and apparatus for sealing access
US8936598B2 (en) * 2009-01-14 2015-01-20 DePuy Synthes Products, LLC Spinal disc preparation tool
EP2393523A4 (en) * 2009-02-06 2014-03-19 Osseous Technologies Of America BIPHASIC OR CAPSULATED COLLAGEN MEMBRANE FOR GUIDED TISSUE REGENERATION
JP5232341B2 (ja) * 2009-06-01 2013-07-10 ミドリホクヨー株式会社 可溶化コラーゲン繊維、及びその製造方法、コラーゲン含有化粧料及びその製造方法、並びに可溶化コラーゲン繊維の製造装置
WO2011019724A1 (en) * 2009-08-10 2011-02-17 Osseous Technologies Of America Self-supporting collagen tunnel for guided tissue regeneration and method of using same
FR2960439B1 (fr) * 2010-05-31 2012-06-15 Univ Paris Curie Matrices fibrillaires denses de collagene pour la reparation tissulaire et leur procede de preparation
US20130011451A1 (en) 2011-07-06 2013-01-10 Diversified Glogal Technologies, Llc Footbed with non-denatured collagen
US10576037B2 (en) 2012-03-14 2020-03-03 MAM Holdings of West Florida, L.L.C. Compositions comprising placental collagen for use in wound healing
US10213523B2 (en) * 2013-02-04 2019-02-26 Northeastern University Mechanochemical collagen assembly
US20140336600A1 (en) 2013-05-10 2014-11-13 Carl Randall Harrell Method for Obtaining Sterile Human Amniotic Fluid and Uses Thereof
US10485521B2 (en) 2013-05-10 2019-11-26 MAM Holdings of West Florida, L.L.C. Method for obtaining sterile human amniotic fluid and uses thereof
US11273183B2 (en) 2015-10-09 2022-03-15 MAM Holdings of West Florida, L.L.C. Amniotic fluid formulation for treatment of joint pain or disorders
US9907821B2 (en) 2015-10-09 2018-03-06 MAM Holdings of West Florida, L.L.C. Amniotic fluid formulation for treatment of joint pain or disorders
US20170100440A1 (en) 2015-10-09 2017-04-13 MAM Holdings of West Florida, L.L.C. Amniotic fluid topical formulation
US20170354692A1 (en) 2016-06-13 2017-12-14 MAM Holdings of West Florida, L.L.C. Amniotic fluid formulation for treatment of lung disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX163953B (es) * 1984-03-27 1992-07-03 Univ New Jersey Med Procedimiento para preparar una matriz biodegradable a base de colageno
US4642117A (en) * 1985-03-22 1987-02-10 Collagen Corporation Mechanically sheared collagen implant material and method
US5475052A (en) * 1988-11-21 1995-12-12 Collagen Corporation Collagen-synthetic polymer matrices prepared using a multiple step reaction
US5106949A (en) * 1989-09-15 1992-04-21 Organogenesis, Inc. Collagen compositions and methods for preparation thereof
US5378469A (en) * 1990-04-06 1995-01-03 Organogenesis, Inc. Collagen threads
WO1994001483A1 (en) * 1992-07-02 1994-01-20 Collagen Corporation Biocompatible polymer conjugates
US5428022A (en) * 1992-07-29 1995-06-27 Collagen Corporation Composition of low type III content human placental collagen

Also Published As

Publication number Publication date
JPH11508782A (ja) 1999-08-03
EP0831882B1 (en) 2004-09-22
ATE276757T1 (de) 2004-10-15
AU6382196A (en) 1996-12-30
US5997896A (en) 1999-12-07
PT831882E (pt) 2005-01-31
EP0831882A1 (en) 1998-04-01
DE69633444D1 (de) 2004-10-28
DE69633444T2 (de) 2006-02-16
WO1996040216A1 (en) 1996-12-19
JP3647465B2 (ja) 2005-05-11
AU722322B2 (en) 2000-07-27
EP0831882A4 (en) 2000-05-03
ES2229277T3 (es) 2005-04-16

Similar Documents

Publication Publication Date Title
BR9609393A (pt) Composição injetável de colágeno; segmentos de fibra de colágeno reconstituìdos.
ID29393A (id) Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah
DE69727158D1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
TR200000927T2 (tr) Prostaglandin agonistleri ve kemik bozukluklarının tedavisi
AR023130A1 (es) Composiciones para promover el crecimiento
ATE218350T1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
BR0306846A (pt) Produto substituto do sangue, composição útil como um substituto do sangue, método para fazer um produto substituto do sangue, e, método de uso de um produto substituto do sangue para fornecer oxigênio a um tecido
ATE169317T1 (de) Pyridobismidazole enthaltendes rigid-rod-polymer
DE69435096D1 (de) Zusammensetzung zur in vivo erzeugung von therapeutischen produkten
ATE279163T1 (de) Gewebedezellularization
ES2168299T3 (es) Composicion farmaceutica que contiene heparina, fragmentos de heparina o sus derivados en combinacion con esteres de glicerol.
DE69326776T2 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
TR200101725T2 (tr) Enteral bileşimler için lif karışımı.
BR9811099A (pt) Inibidores de urocinase
ATE234282T1 (de) Polymorphe verbindungen
FI972703A (fi) Rekombinantti IL-5-antagonisteja, jotka ovat käyttökelpoisia hoidettaessa IL-5:een liittyviä sairauksia
ES2161364T3 (es) Pseudoemulsiones estabilizadas y su procedimiento de preparacion.
FI972434A0 (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
ES2188766T3 (es) Composicion farmaceutica que contiene lamotrigina.
DE69715841T2 (de) Phosphatidsäure enthaltende zusammensetzungen
DE69606321T3 (de) Verwendung von 2-Ethylhexyl-alpha-cyano-beta, beta-diphenylacrylat zur Verbesserung der Lichtstabilität von p-Methylbenzylidencampher
NZ234451A (en) Benzofuran-substituted 2-imidazoline derivatives and pharmaceutical compositions
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
DE69213660D1 (de) Verwendung von 1-(beta-d-arabinofuranosyl)-5-propynyluracil zur senkung des serumcholesterins
EA199900006A1 (ru) Препарат и способ для лечения застоной сердечной недостаточности

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: EM FACE DO EXPOSTO, E COM BASE NOS ARTIGOS 8O, 10, INCISO ( IX E 13 DA LPI 9.279/96 E 229-A DA LEINO 10.196 COMBINADO COM O ARTIGO 37 DA LPI DE 9.279/96, DECIDIMOS PELO INDEERIMENTO DO PRESENTE PEDIDO.

B12B Appeal against refusal [chapter 12.2 patent gazette]